it wil definitely touch 100+ in the next 6 months , what we do know is
- Definitive Agreement provides details of the previously announced intent to co-develop COVAXIN™ for the US market
- Ocugen and Bharat Biotech to share US commercialization profits
- Ocugen to receive initial supply of COVAXIN™ doses from Bharat Biotech upon authorization from US regulatory authorities while it ramps up manufacturing in the US
- COVAXIN™ received EUA (Emergency Use Authorization) in India in January and is currently in a fully enrolled Phase 3 clinical trial involving 25,800 patients
- COVAXIN™ (whole-virion inactivated COVID-19 vaccine candidate) effectively neutralizes UK variant of SARS-Cov-2 reducing the possibility of mutant virus escape
OCGN is waiting on FDA approval
Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN™ in the US Market
get in while its low
that biden/indian prime minster press news is huge